Premier Biomedical, Inc. (BIEI)
OTCMKTS: BIEI · Delayed Price · USD
0.0020
0.0000 (0.00%)
Jun 24, 2022 4:00 PM EDT - Market closed
0.00%
(1D)
| Market Cap | 2.00M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 999.98M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,456,393 |
| Open | 0.0019 |
| Previous Close | 0.0020 |
| Day's Range | 0.0019 - 0.0020 |
| 52-Week Range | 0.0012 - 0.0072 |
| Beta | -4.93 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About BIEI
Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil ca... [Read more...]
Industry
Biotechnology
Founded
2010
CEO
William Hartman
Country
United States
Stock Exchange
OTCMKTS
Ticker Symbol
BIEI
Financial Performance
In 2019, BIEI's revenue was $14,281, a decrease of -64.11% compared to the previous year's $39,795. Losses were -$374,470, -6.12% less than in 2018.
Financial Statements